Literature DB >> 6786580

Pertussis immunisation and serious acute neurological illness in children.

D L Miller, E M Ross, R Alderslade, M H Bellman, N S Rawson.   

Abstract

The first 1000 cases notified to the National Childhood Encephalopathy Study were analysed. The diagnoses included encephalitis/encephalopathy, prolonged convulsions, infantile spasms, and Reye's syndrome. Eighty-eight of the children had had a recent infectious disease, including 19 with pertussis. Only 35 of the notified children (3.5%) had received pertussis antigen within seven days before becoming ill. Of 1955 control children matched for age, sex, and area of residence, 34 (1.7%) had been immunised with pertussis vaccine within the seven days before the date on which they became of the same age as the corresponding notified child. The relative risk of a notified child having had pertussis immunisation within that time interval was 2.4 (p less than 0.001). Of the 35 notified children, 32 had no previous neurological abnormality. A year later two had died, nine had developmental retardation, and 21 were normal. A significance association was shown between serious neurological illness and pertussis vaccine, though cases were few and most children recovered completely.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786580      PMCID: PMC1505512          DOI: 10.1136/bmj.282.6276.1595

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  6 in total

1.  Neurological complications of pertussis inoculation.

Authors:  M Kulenkampff; J S Schwartzman; J Wilson
Journal:  Arch Dis Child       Date:  1974-01       Impact factor: 3.791

2.  Estimation of relative risk from individually matched series.

Authors:  O S Miettinen
Journal:  Biometrics       Date:  1970-03       Impact factor: 2.571

3.  Pertussis vaccination.

Authors:  A L Prensky
Journal:  Dev Med Child Neurol       Date:  1974-08       Impact factor: 5.449

4.  Discrepancies in immunization records.

Authors:  N S Rawson; R Alderslade; D L Miller
Journal:  Community Med       Date:  1980-08

5.  Osteomalacia in rheumatoid arthritis.

Authors:  S O'Driscoll; M O'Driscoll
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

6.  Vaccination against whooping-cough. Efficacy versus risks.

Authors:  G T Stewart
Journal:  Lancet       Date:  1977-01-29       Impact factor: 79.321

  6 in total
  63 in total

1.  Pertussis: the disease and the vaccine.

Authors:  R Gold
Journal:  Can Fam Physician       Date:  1986-01       Impact factor: 3.275

2.  Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.

Authors:  I Marsili; M Pizza; F Giovannoni; G Volpini; M Bartalini; R Olivieri; R Rappuoli; L Nencioni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  The British Paediatric Surveillance Unit: the first 20 years.

Authors:  Richard Lynn; Euan Ross
Journal:  Arch Dis Child       Date:  2007-09       Impact factor: 3.791

4.  Maintenance of biological activity of pertussis toxin radioiodinated while bound to fetuin-agarose.

Authors:  G D Armstrong; M S Peppler
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

5.  Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.

Authors:  P Boucher; H Sato; Y Sato; C Locht
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit.

Authors:  T D Bartley; D W Whiteley; V L Mar; D L Burns; W N Burnette
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 7.  Indications and contraindications for vaccines used in the Expanded Programme on Immunization.

Authors:  A M Galazka; B A Lauer; R H Henderson; J Keja
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

8.  Pertussis toxin is required for pertussis vaccine encephalopathy.

Authors:  L Steinman; A Weiss; N Adelman; M Lim; R Zuniga; J Oehlert; E Hewlett; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 9.  The past, present, and future of pertussis. The role of adults in epidemiology and future control.

Authors:  J D Cherry; L J Baraff; E Hewlett
Journal:  West J Med       Date:  1989-03

10.  Pertussis toxin-induced alterations of murine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed.

Authors:  S Ansher; W Thompson; J Bridgewater; P Snoy
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.